Cleveland Clinic Laboratories
|
|
|
- Robert Andrews
- 8 years ago
- Views:
Transcription
1 Cleveland Clinic Laboratories Anatomic Pathology Special Stains Group I for Microorganisms Special Stains Group I Fite stain Giemsa (h. pylori) Gomori s methenamine silver (GMS) Gram Gridley Steiner PAS/light green counterstain Warthin-Starry Ziehl-Neelsen AFB Stains for mycobacteria leprae Helicobacter Fungus, Pneumocystis, Bacteria Gram-positive and gram-negative bacteria Fungus Spirochetes, Bacteria Fungus Bacteria, Spirochetes Acid-fast mycobacterium Group II (All Other) Special Stains Group II Alcian Blue, ph 2.5 Alcian Blue/Hyaluronidase Alcian Blue/PAS Aldehyde fuchsin Alizarin Red S ASD Leder s modification Bielschowsky Bile, Hall s method Bodian Colloidal iron Colloidal Iron/Hyaluronidase Congo Red Copper (Rhodanine) Crystal Violet Elastic stain (EVG) Fontana-Masson Giemsa (mast cell) Grimelius Iron stain Jones methenamine silver Luxol fast blue Masson trichrome Melanin bleach Movat Mucicarmine Oil Red O Orcein PAS/amylase (PAS/D) Periodic acid-schiff (PAS) PTAH Reticulum SAB Thioflavin S Acid mucopolysaccharides Differentiation of epithelial and connective tissue mucins Acid and neutral mucins Copper-binding protein, Elastic fibers Calcium Esterase, Mast cells Neurofibrils Bilirubin Nerve fibers Mucopolysaccharides, Collagen Differentiation of epithelial and connective tissue mucins Copper Elastic fibers, Collagen Argentaffin granules or Melanin Eosinphilic granules and Mast cells Argyrophil granules, Argentaffin Iron Basement membranes, Reticular fibers Myelin Collagen Eliminates melanin Elastic fibers, Collagen, Mucin, Fibrin and Muscle Mucosubstances Fat Copper-binding Protein, Elastic fibers Eliminates glycogen Glycogen, Neutral mucopolysaccharides and Basement membranes Collagen, Fibrin, Coarse elastic fibrils Stains for reticulum fibers 9500 Euclid Avenue Cleveland, Ohio clevelandcliniclabs.com
2 Group II (All Other cont.) Special Stains Group II Toluidine Blue Uric acid Von Kossa Histochemical Stains (Enzyme) Acetylcholinesterase (ACE) Acid phosphatase Alkaline phosphatase ATP (4.6, 9.8) Cytochrome C Esterase NADH Phosphofructokinase Phosphorylase Succinic dehydrogenase (SDH) Mast cell granules Urate crystals Calcium Nerve fibers/hirschsprung s disease Muscle fibers undergoing degeneration Basement membranes and regenerating fibers Muscle fiber types Cytochrome oxidase Denervated muscle fibers Whorls, Target fibers, Central cores, Moth-eaten fibers PFK activity Phosphorylase activity Mitochondrial disease Immunohistochemistry Stains Stain ACTH Human adrenocorticotropic hormone Actin HHF35 Human muscle actin Actin SM Alpha-smooth muscle isoform, Myoepithelium, etc. Adenovirus Adenovirus AFP Alpha fetoprotein ALK (D5F3) Anaplastic lymphoma kinase, clone D5F3 ALK-1 ALK-1 A (AMY-A) Kappa (AMY-K) Lambda (AMY-L) Androgen Recept Androgen Receptor ß-Catenin Beta Catenin BCL-2 Follicular lymphoma, Apoptosis inhibin protein BCL2 EP36 BCL2, clone EP36 BCL-6 Follicular and diffuse lymphomas, Burkitt s lymphoma & Lymphocyte predominant Hodgkin s disease B72.3 Tumor associated glycoprotein BOB-1 Transcription coactivator for Oct-1 and Oct-2 CA9 Carbonic Anhydrase IX CA 125 Tumor marker for ovarian, endometrial, breast, GI cancer Calcitonin (CALC) Calcitonin Calretinin (CALR) Calcium-binding protein, Mesothelial cells C3d Complement 3d, transplant rejection biomarker C4d Complement 4d, transplant rejection biomarker 2
3 E-cadherin (CADH) Epithelial marker EGFR Epithelial growth-factor receptor EMA Epithelial membrane antigen Enolase (NSE) Neuron specific enolase EP4-Ber Epithelial antigen ERG Vascular marker and prostate malignancy marker ER Estrogen receptor Factor VIII Von Willebrand factor, Endotheium and megakaryocytes Factor XIII Fibrohistiocytic tumors, Dendritic interstitial cells Fascin Hodgkin s disease, High grade breast carcinoma FGFR3 CD333, Fibroblast growth factor receptor 3 FOXP1 Prognosis of lymphoma, leukemia, carcinoma FOX-P3 T regulatory cell marker FSH Follicle stimulating hormone Galectin Inflammation and cancer Gastrin Gastrin secreting tumors, G-cell hyperplasia GCDFP-24 Gross cystic disease fluid protein-15 GCET1 Germinal center B-cell marker GFAP Human glial fibrillary acidic protein GH Growth hormone Granzyme-B Serine protease HBcAg Hepatitis B core antigen HBsAg Hepatitis B surface antigen H-Caldesmon (HCAL) Smooth muscle differentiation H.pylori Helicobacter pylori ßHCG HCG in trophoblastic elements of germ cell tumors Hepatocyte Hep-par1 Herpes (HSVI&II) HSV I/II HER2 Neu (4B5) Erb-2 oncoprotein, Clone 4B5 HHV8 Human herpesvirus 8 HMB 45 Melanoma associated marker HPV Human papilloma virus subtype IDH-1 Glioma Marker IgA Immunoglobulin A IgD Immunoglobulin D IgG Immunoglobulin G IgG4 Autoimmune pancreatitis IgM Immunoglobulin M INI1 Malignant rhabdoid tumor marker Inhibin Granulosa cell tumor, Sex cord stromal tumor Ki67 Cell proliferation marker Kappa Kappa light chain Lambda Lambda light chain Langerin Langerhans cell histiocytosis LEF1 Chronic lymphocytic (CLL)/small lymphocytic (SLL) leukemias LH Luteinizing hormone 3
4 E-cadherin (CADH) Epithelial marker EGFR Epithelial growth-factor receptor EMA Epithelial membrane antigen Enolase (NSE) Neuron specific enolase EP4-Ber Epithelial antigen ERG Vascular marker and prostate malignancy marker ER Estrogen receptor Factor VIII Von Willebrand factor, Endotheium and megakaryocytes Factor XIII Fibrohistiocytic tumors, Dendritic interstitial cells Fascin Hodgkin s disease, High grade breast carcinoma FGFR3 CD333, Fibroblast growth factor receptor 3 FOXP1 Prognosis of lymphoma, leukemia, carcinoma FOX-P3 T regulatory cell marker FSH Follicle stimulating hormone Galectin Inflammation and cancer Gastrin Gastrin secreting tumors, G-cell hyperplasia GCDFP-24 Gross cystic disease fluid protein-15 GCET1 Germinal center B-cell marker GFAP Human glial fibrillary acidic protein GH Growth hormone Granzyme-B Serine protease HBcAg Hepatitis B core antigen HBsAg Hepatitis B surface antigen H-Caldesmon (HCAL) Smooth muscle differentiation H.pylori Helicobacter pylori ßHCG HCG in trophoblastic elements of germ cell tumors Hepatocyte Hep-par1 Herpes (HSVI&II) HSV I/II HER2 Neu (4B5) Erb-2 oncoprotein, Clone 4B5 HHV8 Human herpesvirus 8 HMB 45 Melanoma associated marker HPV Human papilloma virus subtype IDH-1 Glioma Marker IgA Immunoglobulin A IgD Immunoglobulin D IgG Immunoglobulin G IgG4 Autoimmune pancreatitis IgM Immunoglobulin M INI1 Malignant rhabdoid tumor marker Inhibin Granulosa cell tumor, Sex cord stromal tumor Ki67 Cell proliferation marker Kappa Kappa light chain Lambda Lambda light chain Langerin Langerhans cell histiocytosis LEF1 Chronic lymphocytic (CLL)/small lymphocytic (SLL) leukemias LH Luteinizing hormone 4
5 LMO2 Large B-cell lymphoma marker MDM2 Liposarcoma Melan A Malignant melanoma marker MiTF Melanocyte development regulator, melanoma oncogene MLH-1 Mismatch repair gene MLH-1 MOC-31 Differentiate carcinomas from mesothelial cells and mesotheliomas MSH-2 Mismatch repair gene MSH-2 MSH-6 Mismatch repair gene MSH-6 MUM-1 Multiple myeloma oncogene-1 Muramidase Muramidase/Lysozyme Myeloperoxidase Neutrophilic granulocytes and monocytes MyoD1 Rhabdomyosarcoma marker Myogenin Rhabdomyosarcoma marker Myoglobin Human heart Neurofilament Neurofilament Neurofilament Cocktail Cocktail of clones 2F11 and SMI-32 NKI/C3 Melanoma marker OCT-2 Octamer transcription factor 2 OCT3/4 Marker for undifferentiated cells p16 Cervical cancer marker P501s Protein Confirm prostatic origin of metastatic carcinoma p53 Overexpression of the p53 oncogene p57 Differential diagnosis of complete vs partial hydatidiform molar pregnancy p63 Prostate cancer marker p63/erg Double Stain A double stain for prostate cancer PAP Normal hyperplastic and neoplastic, Prostatic cells PAX-2 Tumor marker for kidney, prostate, breast, ovary PAX-5 B-cell specific activator protein PAX-8 Nephritic cell lineage marker P-Component Perforin T-cell and NK cell lymphoma PD1 T-cell regulator PDGFR oligodendrocytic progenitor cells PIN cocktail (p63&amacr) p63 and AMACR Prolactin Prolactin in pituitary PLAP Placental alkaline phosphatase, Germ cell and adenocarcinoma PMS2 Mismatch repair gene PMS-2 PR Progesterone receptor PSA Prostate specific antigen PSMA Prostate specific membrane antigen PTEN Differentiate breast, prostate carcinoma from normal PTH Parathyroid hormone Racemase (AMACR) Prostate adenocarcinoma marker RCC Renal Cell Carcinoma marker S-100 S100 protein SALL4 Yolk sac tumor marker Serotonin Carcinoid syndrome SMMS1 Smooth muscle myosin pstat 5 Surrogate marker of JAK2 V617F mutation 5
6 Synaptophysin Synaptophysin Syph T. pallidum TCL-1A Mature T-cell leukemia TCR ß F1 T-cells TCR-Gamma T-cells TdT Blasts, Immature lymphocytes TFE-3 Xp11 translocation renal cell carcinoma Thyroglobulin Thyroglobulin TIA Cytolytic effector cells in lymphocytic infiltrates Transthyretin Tryptase (MC trypt) Human mast cells TSH Thyrotropic cells of pituitary TTF-1 Thyroid and pulmonary carcinomas Tyrosinase Metastatic melanoma Ubiqutin Neurofibrillary tangles of Alzheimer s disease Vimentin Vimentin VS38C Plasma cell WT1 (6F-H2) Wilms tumor Sigma, epithelial cell marker CISHs (+NEG & ALU or U6) CISH EBER Chromogenic in situ hybridization for EBV CISH HPV High risk chromogenic in situ hybridization for high risk HPV subtypes; low risk chromogenic in situ hybridization for low risk HPV subtypes CISH Kappa Chromogenic in situ hybridization for Kappa CISH Lambda Chromogenic in situ hybridization for Lambda KERATINS (App/T/Prost) AE1/3 Keratin cocktail: 40, 48, 50, 50, 6, 58, 65, 5 kd CAM 5.2 Keratin: 39, 43, 500 kd CK 5/6 Intermediate filament protein, Cytokeratin 5/6 CK 7 Keratin: 54 kd CK 19 Human cytokeratin 19 polypeptide CK 20 Keratin: 54 kd KER 903 High molecular weight cytokeratins Every life deserves world class care Euclid Avenue, Cleveland, OH Cleveland Clinic is an integrated healthcare delivery system with a main campus. 18 family health centers, eight community hospitals and locations in Ohio, Florida, Nevada, Toronto and Abu Dhabi. It is a not-for-profit group practice where nearly 3,000 staff physicians and scientists in 120 medical specialties collaborate to give every patient the best outcome and experience. Cleveland Clinic is ranked among America s top hospitals overall, and among the nation s leaders in every major medical specialty (U.S.News & World Report). clevelandclinic.org The Cleveland Clinic Foundation
Cleveland Clinic Laboratories
Cleveland Clinic Laboratories Anatomic Pathology Special Stains Group I for Microorganisms Special Stains Group I 88312 Fite stain Gomori s methenamine silver (GMS) Gram Gridley PAS/light green counterstain
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University College London, operating UK NEQS for ccredited to UK NEQS ICC & ISH
CatalogNo Product Name Size
SIG-3250-1000 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) SIG-3250-16 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) L1 6mL SIG-3250-26 α-1-antichymotrypsin Polyclonal Antibody,
Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin
A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,
NEU IM PROGRAMM. LOXO Antikörper für die Immunhistochemie (alphabetisch nach Bezeichnung sortiert) Art.Code Artikelbezeichnung Typ Einsatz Einheit
A20002 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 2 ml Ready-to-use A00002.0025 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 25 ml Ready-to-use A00002 Actin, Alpha-Smooth Muscle; Clone
A23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
Ovarian tumors Ancillary methods
Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.
Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case
Practical Effusion Cytology
Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.
How To Test For Cancer
Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic
Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!
Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of
page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9)
New IHC Antibodies 2 Table of Contents page antibody 1 2 3 4 5 6 7 8 Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) Caveolin-1 (2297) CD13 (SP187) CD16 (SP175)
Immunohistochemistry of soft tissue tumors
Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated
Effusions: Mesothelioma and Metastatic Cancers
Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,
HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download
AP2003R1 http://hkcpath.org. Correspondence: pkhui@ha.org.hk 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from
How To Test For Cancer With A Blood Test
Histolab Products AB Eva Alströmer Jonas Falgén Helsingborg 7-8/10 2010 Table 1 Formalin Fixation Times and Estrogen Receptor Staining With 25 Minutes Antigen Retrieval Pretreatment Formalin Q-Score Difference
Immunohistochemistry (IHC) Outreach Services
Immunohistochemistry (IHC) Outreach Services Note t ype of fixative used if not neutral buffered f ormalin. Note t ype of tissue/specim en Unless specified otherwise, positive and negative controls react
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have
Laboratory examination in patients with tumours
Tumour markers Marta Kalousová Institute of Clinical Chemistry and Laboratory Diagnostics, 1 st Faculty of Medicine and General University Hospital, Charles University, Prague Laboratory examination in
The develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
Outline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
M061301-2 1 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M061329-2 0,2 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M061601-2 1 ml Mo a Hu
M061301-2 1 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M061329-2 0,2 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M061601-2 1 ml Mo a Hu Von Willebrand Factor, Clone F8/86 M061701-2 1 ml Mo
Lessons from a consultation practice
Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter
Malignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls
Aus dem Institut für Pathologie der Medizinischen Fakultät Charité Universitätsmedizin Berlin DISSERTATION Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls
Diagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.
Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell
RENAL CELL CARCINOMA EPIDEMIOLOGY
RENAL CELL CARCINOMA: THE 2012 ISUP VANCOUVER CLASSIFICATION David Grignon MD, Indiana University, Indianapolis, IN RENAL CELL CARCINOMA EPIDEMIOLOGY Siegel et al. CaA Cancer J Clin 63:11-30, 2013 1 EPITHELIAL
Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1
Immunohistochemistry of clear cell tumours J. Klos MD Department of Pathology Stavanger University Hospital Norway What are clear cell tumours? Multiple factors in etiology of clear cell changes: - technical
Special histochemical stains are routinely used for the interpretation
Technical Articles Special Stains in Interpretation of Liver Biopsies Rashmil Saxena, BFA, HT(ASCP) CM Division of Transplantation Department of Surgery, Indiana University Indianapolis, IN, USA Special
immunohistochemistry stain offerings
immunohistochemistry stain offerings TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS. www.aruplab.com/ap-ihc JULY 2015 Information in this brochure is current as of July 2015. All content is subject to change.
Renal Pathology Update. Sundus Hussein MD, FRCPC
Renal Pathology Update Sundus Hussein MD, FRCPC Case History A 45 year old male with incidentally discovered a 3.5 x 3.9 x 2.7 cm renal mass Handling partial nephrectomy Handling partial nephrectomy
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND
Pathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids
Cytology of Effusion Fluids John W. Wong, MD, FRCPC Sunnybrook Health Sciences Centre Assistant Professor, Laboratory Medicine and Pathobiology Faculty of Medicine, University of Toronto November 10, 2012
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD
Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic
specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
Breast cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Breast cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-7227 Hs 281.T CRL-7245 Hs
MODERN IMMUNOHISTOCHEMISTRY
MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,
The term undifferentiated tumor has been used in reference
Undifferentiated Tumor True Identity by Immunohistochemistry Armita Bahrami, MD; Luan D. Truong, MD; Jae Y. Ro, MD, PhD Context. Undifferentiated tumor refers to a heterogeneous group of neoplasms with
The Endocrine System
Essentials of Human Anatomy & Physiology Elaine N. Marieb Seventh Edition Chapter 9 The Endocrine System Slides 9.1 9.48 Lecture Slides in PowerPoint by Jerry L. Cook The Endocrine System Second messenger
Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities
Pathology of Renal Neoplasia Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities Wael A Sakr, MD Wayne State University School of Medicine CURRENT CLASSIFICATION = EPITHELIAL
A Better Path for Cancer Diagnostics
INTERPRETATION FLEX Ready-to-Use Atlas of Stains - 4 th Edition A Better Path for Cancer Diagnostics Committed to raising the bar for higher quality During the last decades, organizations such as CAP,
Hormones: Classification. Hormones: Classification. Peptide Hormone Synthesis, Packaging, and Release
Hormones: Classification Hormones: Classification Be able to give types and example. Compare synthesis, half-life and location of receptor 1. Peptide or protein hormones Insulin from amino acids 2. Steroid
What is special about a stain, and why do we call some stains
Technical Articles Evolution of Use of Special Stains Alton D. Floyd, PhD Independent Consultant Edwardsburg, MI, USA What is special about a stain, and why do we call some stains special? We all think
Determination of the type and origin of metastatic
Diagnosis of Metastatic Neoplasms An Immunohistochemical Approach Murli Krishna, MD N Context. It is important to determine the type and/or site of origin of metastatic tumors for optimal clinical management.
Abstracts and References
Abstracts and References Soft Tissue Pathology Professor Cyril Fisher, Royal Marsden Hospital Learning points CD34 and CK positivity coexist in epithelioid sarcoma and epithelioid endothelial tumours.
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu
Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Table of Contents Page Undifferentiated panel 1 CK7/20 table 2 Breast carcinoma
Immunohistochemical classification of malignant lymphomas
Immunohistochemical classification of malignant lymphomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Thanks to Jan Klos Important issues Distinction from non-hematopoietic neoplasms
Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin
Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Rodney T. Miller, M.D. Director of Immunohistochemistry ProPath Laboratory 1355 River Bend Drive Dallas, TX 75247-4915
KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.
KEY CHAPTER 14: BLOOD OBJECTIVES 1. Describe blood according to its tissue type and major functions. TISSUE TYPE? MAJOR FUNCTIONS connective Transport Maintenance of body temperature 2. Define the term
The Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
Ch16 Endocrine part 2
Ch16 Endocrine part 2 several separate organs release hormones into capillaries hormones are transported in the blood Hypothalamus Pituitary glands Pineal gland Thyroid Parathyroid Thymus Adrenal Cortex
What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
Hepatitis C. Laboratory Tests and Hepatitis C
Hepatitis C Laboratory Tests and Hepatitis C If you have hepatitis C, your doctor will use laboratory tests to check your health. This handout will help you understand what the major tests are and what
Definitions. Carcinoma. Sarcoma Any cancer of connective tissue, e.g. muscle, fat, bone, lymphatic vessels.
Tumor markers Drahomíra Bezdíčková ÚKBLD VFN a 1.LF UK Carcinoma Definitions Cancer that arises from the epithelium, the tissue that lines the internal organs of the body. Sarcoma Any cancer of connective
Endocrine System Review Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.
Endocrine System Review Graphics are used with permission of: Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com) Page 1. Endocrine System Review Consists of discrete individual
Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
Excellent FFPE. Staining
Outstanding Markers Excellent FFPE Staining Superior Staining Quality High Titer Best Price O P T I S TA I N Anti-PD-1 (clone NAT105) - a marker for follicular helper T cells (T FH ) and T-cell lymphomas
Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA
Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia
Name (print) Name (signature) Period. (Total 30 points)
AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,
Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12
Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background
Cytopathology Case Presentation #8
Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents
Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed
Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms Dr. Douaa Mohammed Sayed Small lymphocytic lymphoma/b-cell chronic lymphocytic leukemia BMB: nodular, interstitial, diffuse or a combination
NEOPLASIA (4) Tumor-Host Interactions and Systemic Effects of Neoplasms
NEOPLASIA (4) Tumor-Host Interactions and Systemic Effects of Neoplasms Rex Bentley, M.D. Department of Pathology M216A, Duke South Green Zone Rex.Bentley@duke.edu 684-6423 NEOPLASIA (IV) Goals and Objectives
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
STEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
2006 7.012 Problem Set 6 KEY
2006 7.012 Problem Set 6 KEY ** Due before 5 PM on WEDNESDAY, November 22, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You create an artificial
MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER
Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC
This module consists of four units which will provide the user a basic knowledge of cancer as a disease.
Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define
Diagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
Colon cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Colon cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-2577 RKO Carcinoma CRL-2579
Stem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
Fight or Flight Response: Play-by-Play
One of the most remarkable examples of cell communication is the fight or flight response. When a threat occurs, cells communicate rapidly to elicit physiological responses that help the body handle extraordinary
Proteins. Protein Trivia. Optimizing electrophoresis
Proteins ELECTROPHORESIS Separation of a charged particle in an electric field Michael A. Pesce, Ph.D Department of Pathology New York-Presbyterian Hospital Columbia University Medical Center Rate of migration
- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa
- Slide Seminar - Endocrine pathology in non-endocrine organs Case 11 Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa Dept. of Pathology, Multimedica, Milan, Italy Dept. of Surgical and Morphological
Common Cancers & Hereditary Syndromes
Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.
About B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification
regulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon
Hormonal Effects regulation of ECF composition and volume ADH, aldosterone, ANF regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon regulation of muscle contraction
Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
Case of the. Month October, 2012
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern
Common Morphologic Patterns in Soft Tissue Tumors John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology The Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine
How To Diagnose And Treat A Tumour In An Effusion
Effusions of the Serous Cavities Annika Dejmek Professor/Consultant in Cytopathology Clinical Pathology; Department of Laboratory Medicine, Malmö, Lund University 5th EFCS Tutorial Trondheim 2012 Pleura
Immuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
Tumor Markers. What are tumor markers? How are tumor markers used? Screening and early detection of cancer
Tumor Markers What are tumor markers? Tumor markers are substances that can be found in the body when cancer is present. Ideally, a tumor marker would always be found in the blood in higher-than-normal
http://www.springer.com/3-540-22006-2
http://www.springer.com/3-540-22006-2 1 Molecular Pathology Laboratory of the Future Christopher A. Moskaluk 1.1 The Past The integration of laboratory analysis with human medicine has traditionally been
EU Declaration of Conformity
EU Declaration of Conformity Omega Diagnostics Omega House Hillfoots Business Village Alva Scotland United Kingdom FK12 5DQ Manufacturer Identification Code GB / 000072 Medicines and Healthcare Products
Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology
Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists
Supplemental Material CBE Life Sciences Education. Su et al.
Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select
FNA Cytology of Mediastinal Lesions. Presenters: Xiaoqi Lin, M.D., Ph.D. Ritu Nayar, M.D.
Disclosure information The speakers have no relationship that represents a possible conflict of interest with respect to the content of this presentation. FNA Cytology of Mediastinal Lesions Presenters: